2011

Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays.
Gabbiani, C., Mastrobuoni, G. ORCID: https://orcid.org/0000-0003-4509-1295, Sorrentino, F., Dani, B., Rigobello, M.P., Bindoli, A., Cinellu, M.A., Pieraccini, G., Messori, L. and Casini, A.
MedChemComm 2 (1): 50-54. January 2011